OUR STORY.

In 2014, after decades of research, an AI pioneer (Professor Agnar Hoskuldsson) and a world renowned clinician (Professor Henrik Verder) formed a partnership committed to realizing the full potential of AI in healthcare. With a team of the best data scientists, technologists and clinical researchers, they developed a powerful AI Platform that can deliver decisive data-driven results in minutes, discover new disease biomarkers and curate unique datasets. Five years, and multiple clinical trials later, their AI Platform has demonstrated it’s accuracy as a neonatal clinical tool and it’s effectiveness as a biomarker discovery platform.

Founders & Chiefs

Agnar Hoskuldsson
mathematician & CO-FOUNDER
World renowned mathematician and winner of the Herman Wold Gold Medal for pioneering modern chemometrics. Former associate professor at the Technical University of Denmark. Published 40+ papers, with over 1,600 scientific citations.
Wikipedia
Henrik VERDER
CLINICIAN & CO-FOUNDER
Pediatrician and inventor of the INSURE method, the current gold standard of care for Respiratory Distress Syndrome (RDS). In 1989, he successfully treated the first premature infant with the INSURE method. He has published +50 papers, cited over 1,000 times.

Wikipedia

POVL VERDER
CEO & CO-FOUNDER
An experienced entrepreneur, medical technologist and digital strategist. Founder of beCogent Ltd (£35m exit) and previously held senior roles with BSkyB and NewsCorp. Former advisor to Johnson & Johnson, GlaxoSmithKline, and Coloplast. 

LinkedIn

BOARD

MIKE TREVINO
NON-EXECUTIVE DIRECTOR
Technologist and entrepreneur. Founder & CEo of Indigenous Software and former CTO of NantHealth.

LinkedIn

Palle Andersen
NON-EXECUTIVE CHAIRMAN
Partner at Advodan Law. Experienced healthcare policy maker.

LinkedIn

MANUEL Piñuela
EXECUTIVE DIRECTOR
Founder and technology entrepreneur. Advisor and co-founder of Drayson Technologies and Sensyne Health (AME LSE IPO – £225m).

LinkedIn